Targeting immune response induction with cochleate and liposome-based vaccines.
The immune response generated by infection with a pathogenic organism, or by vaccination with a live attenuated or whole killed pathogen, often does not stimulate optimal protection against that organism. Lipid matrix-based subunit vaccines can be used to produce custom-designed vaccines, that elicit desired immune responses targeted to specific parts of the pathogen that are relevant to protection. Harmful or competitive responses can be minimized or avoided. Earlier work with liposomes has allowed the development of a new class of subunit vaccines called cochleate delivery vehicles, whose structure and properties are very different from liposomes. Protein and DNA cochleates are highly effective vaccines when given via mucosal or parenteral routes, including oral, intranasal, intramuscular, or subcutaneous. Strong, long-lasting, mucosal and circulating, antibody and cell-mediated responses are generated. Protection from challenge with live viruses following oral or intramuscular administration has been achieved.